Oxidative stress in bronchopulmonary disease: contribution of N-acetylcysteine (NAC) (Q46384895)

21 December 2017

review article

1 reference

title

Oxidative stress in bronchopulmonary disease: contribution of N-acetylcysteine (NAC) (English)

1 reference

21 December 2017

1 reference

J-C Guerin

1

1 reference

21 December 2017

P Leophonte

2

1 reference

21 December 2017

F-X Lebas

3

1 reference

21 December 2017

F Liard

4

1 reference

21 December 2017

Ph Terrioux

5

1 reference

21 December 2017

P Boulanger

6

1 reference

21 December 2017

language of work or name

French

0 references

publication date

1 February 2005

1 reference

21 December 2017

Revue de pneumologie clinique

published in

1 reference

21 December 2017

volume

61

1 reference

21 December 2017

issue

1 Pt 1

1 reference

21 December 2017

page(s)

16-21

1 reference

21 December 2017

Role of oxidants/antioxidants in smoking-induced lung diseases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Oxidative Stress in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Exhaled nitric oxide in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Cellularity of the alveolar walls in smokers and its relation to alveolar destruction. Functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Neutrophil Retention in the Lungs of Patients with Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Decreased Leukocyte Deformability after Acute Cigarette Smoking in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic air-flow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Pulmonary lipid peroxidation in cigarette smokers and lung cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Systemic oxidative stress in asthma, COPD, and smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Extracellular release of hydrogen peroxide by human alveolar macrophages: the relationship to cigarette smoking and lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Genes, oxidative stress, and the risk of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Increased alveolar epithelial permeability in cigarette smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Lung protection by a thiol-containing antioxidant: N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

The metabolism of N-acetylcysteine by human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Alteration of the erythrocyte glutathione redox balance by N -acetylcysteine, captopril and exogenous glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Comparative study on the selenium- and N-acetylcysteine-related effects on the toxic action of hyperoxia, paraquat and the enzyme reaction hypoxanthine-xanthine oxidase in cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Mechanism of action of paracetamol protective agents in mice in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Stimuli-induced superoxide radical generation in vitro by human alveolar macrophages from smokers: modulation by N-acetylcysteine treatment in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

N-acetylcystein in the therapy of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8417%2805%2984777-7

7 January 2021

10.1016/S0761-8417(05)84777-7

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017